Medytox (Exclusive Right To Develop Neurotoxin Products)

Business Data, Corporate Office and Headquarter Address

About

Medytox (Exclusive Right To Develop Neurotoxin Products) is Buildings and Property in South Korea that focus on portfolio business. They cover business area such as portfolio, right, neurotoxin product, Korea, Japan.

Business Type

Buildings and Property

Country

South Korea

Founded

-

Company Focus

Portfolio

Website

-

Corporate Office and Headquarter Office address:

78, Gagni 1-Gil, Ochang-Eup
Cheongwon-Gu, Chungcheongbuk-Do
Cheongju, 363-883
South Korea

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

portfoliorightneurotoxin productKoreaJapan

* We use standard office opening hours in near Medytox (Exclusive Right To Develop Neurotoxin Products)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Medytox (Exclusive Right To Develop Neurotoxin Products) Frequently Asked Questions

What or who is Medytox (Exclusive Right To Develop Neurotoxin Products)?

Medytox (Exclusive Right To Develop Neurotoxin Products) is Buildings and Property business from South Korea that founded in - ( years old in ), Medytox (Exclusive Right To Develop Neurotoxin Products) business is focusing on Portfolio.

Where is Medytox (Exclusive Right To Develop Neurotoxin Products) headquarter and corporate office address?

Medytox (Exclusive Right To Develop Neurotoxin Products) headquarter office and corporate office address is located in 78, Gagni 1-Gil, Ochang-Eup Cheongwon-Gu, Chungcheongbuk-Do Cheongju, 363-883 South Korea.

Where is Medytox (Exclusive Right To Develop Neurotoxin Products) country origins?

Medytox (Exclusive Right To Develop Neurotoxin Products) was founded in South Korea.

What is Portfolio business focus on?

In , Medytox (Exclusive Right To Develop Neurotoxin Products) is currently focus on portfolio sector.

Portfolio Business Interest from Google Trend

Above is snippet of Google Trends for "portfolio" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Medytox (Exclusive Right To Develop Neurotoxin Products), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.